ARIA Related Momentum Movers
-
Ariad (ARIA) Shares Plunge 10+% as Results of Phase 2 Study of Ponatinib Show Serious Side Effects
-
Ariad Pharma (ARIA) Shares Rise as CEO Sees FDA Approval for Leukemia Drug Next Year
-
ARIAD (ARIA) Reports Statistically Significant Results From Phase 2 Trial of Oral Ridaforolimus
-
Ariad Pharmaceuticals (ARIA) Jumps On Positive Trial Data
-
A Look At Yesterday's Momentum Movers: FNET, RTEC, CLHB, POS, PSPT, FEIC, ARIA & LEA
-
Ariad Pharma (ARIA) Re-Opens After Positive Rulilng
-
UPDATE: ARIAD (ARIA) Confirms Positive Ruling in Eli Lilly (LLY) Patent Infringement Case
-
Ariad Pharma (ARIA): Jury Ruled Eli Lilly (LLY) Infriged Patent - CNBC
-
Biotech Movers from ASCO
Back to ARIA Stock Lookup
